Covestor
MDGL icon

Covestor’s Madrigal Pharmaceuticals MDGL Stock Holding History

Covestor’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$65K Buy
129
+1
+0.8% +$528 0.04% 603
2026
Q2 		$69K Sell
128
-16
-11% -$8.2K 0.04% 597
2026
Q1 		$76K Sell
144
-165
-53% -$78.8K 0.05% 429
2025
Q4 		$180K Buy
309
+268
+654% +$137K 0.09% 265
2025
Q3 		$19K Hold
41
– – 0.01% 1292
2025
Q2 		$13K Sell
41
-1
-2% -$298 0.01% 1415
2025
Q1 		$14K Hold
42
– – 0.01% 1314
2024
Q4 		$13K Hold
42
– – 0.01% 1391
2024
Q3 		$9K Hold
42
– – 0.01% 1619
2024
Q2 		$12K Buy
42
+1
+2% +$238 0.01% 1417
2024
Q1 		$11K Sell
41
-24
-37% -$5.66K 0.01% 1520
2023
Q4 		$15K Buy
65
+38
+141% +$6.65K 0.01% 1306
2023
Q3 		$4K Hold
27
– – ﹤0.01% 1743
2023
Q2 		$6K Sell
27
-1
-4% -$271 ﹤0.01% 1680
2023
Q1 		$7K Buy
28
+26
+1,300% +$7.08K 0.01% 1472
2022
Q4 		$1K Hold
2
– – ﹤0.01% 1898
2022
Q3 		$0 Sell
2
-1
-33% -$69 ﹤0.01% 2344
2022
Q2 		$0 Hold
3
– – ﹤0.01% 2175
2022
Q1 		$0 Sell
3
-1
-25% -$84 ﹤0.01% 2301
2021
Q4 		$0 Buy
+4
New +$329 ﹤0.01% 2222

Other funds holding MDGL

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return

Covestor's MDGL Position: Q3 2026 in Review

Covestor increased its Madrigal Pharmaceuticals (MDGL) stake by 0.78% in Q3 2026, buying an estimated $528 and bringing the position to 129 shares worth $65K. The position accounts for 0.04% of the portfolio, ranked #603.

Covestor first reported a position in MDGL in Q4 2021 and has held it in 20 quarters since. The position peaked at $180K in Q4 2025. 332 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • Covestor held 129 shares of Madrigal Pharmaceuticals worth $65K as of Q3 2026.
  • Covestor bought 1 Madrigal Pharmaceuticals share in Q3 2026, an estimated $528.
  • Madrigal Pharmaceuticals made up 0.04% of Covestor's portfolio in Q3 2026, its #603 holding.
  • Covestor first reported a position in Madrigal Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
  • Covestor's Madrigal Pharmaceuticals position peaked at $180K in Q4 2025.
  • 332 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.